Skip to main content

Table 2 Selected characteristics of screen-detected and interval cancers

From: Mammographic features associated with interval breast cancers in screening programs

 

Mean (SD)

Pvaluea

Screen detected N?=?718

Interval cancers N?=?125

Age (years)

57.2 (9.0)

52.8 (8.3)

<0.0001

Body mass index (kg/m2)

25.3 (4.3)

23.9 (3.5)

0.0008

Age at menarche (years)

12.9 (1.5) N?=?701

12.8 (1.6) N?=?122

0.76

Parity (% parous)

84.3

82.4

0.60

Age at first live birth (years)

24.7 (4.6) N?=?605

24.7 (4.8) N?=?103

0.96

Number of live births

2.53 (1.8)

2.32 (1.6)

0.24

Menopausal status (% post-menopausal)

78.3

57.6

<0.0001

Age at menopause (years)

46.7 (6.8) N?=?496

47.1 (5.9) N?=?67

0.49

Current use of HRTb (% yes)

18.3

20.8

0.50

Previous breast biopsy (% yes)

16.6 N?=?709

21.8 N?=?124

0.17

First-degree relatives with breast cancer (% yes)

20.6 N?=?714

20.0

0.88

Percent mammographic density

30.3 (19.1)

42.2 (20.4)

<0.0001

Dense area (cm2)

36.7 (25.6)

45.3 (28.5)

0.001

Non-dense area (cm2)

100.4 (60.1)

67.2 (44.6)

<0.0001

Total area (cm2)

137.0 (60.4)

112.5 (54.2)

<0.0001

  1. aP value is from the univariable logistic regression model analysis of risk of interval vs. screen-detected breast cancer; bhormone replacement therapy.